• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎性 CD4/CD8 双阳性人类 T 细胞源自反应性 CD8 T 细胞,足以介导移植物抗宿主病病理学。

Inflammatory CD4/CD8 double-positive human T cells arise from reactive CD8 T cells and are sufficient to mediate GVHD pathology.

机构信息

Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.

Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.

出版信息

Sci Adv. 2023 Mar 24;9(12):eadf0567. doi: 10.1126/sciadv.adf0567.

DOI:10.1126/sciadv.adf0567
PMID:36961891
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10038349/
Abstract

An important paradigm in allogeneic hematopoietic cell transplantations (allo-HCTs) is the prevention of graft-versus-host disease (GVHD) while preserving the graft-versus-leukemia (GVL) activity of donor T cells. From an observational clinical study of adult allo-HCT recipients, we identified a CD4/CD8 double-positive T cell (DPT) population, not present in starting grafts, whose presence was predictive of ≥ grade 2 GVHD. Using an established xenogeneic transplant model, we reveal that the DPT population develops from antigen-stimulated CD8 T cells, which become transcriptionally, metabolically, and phenotypically distinct from single-positive CD4 and CD8 T cells. Isolated DPTs were sufficient to mediate xeno-GVHD pathology when retransplanted into naïve mice but provided no survival benefit when mice were challenged with a human B-ALL cell line. Overall, this study reveals human DPTs as a T cell population directly involved with GVHD pathology.

摘要

同种异体造血细胞移植(allo-HCT)中的一个重要模式是预防移植物抗宿主病(GVHD),同时保留供体 T 细胞的移植物抗白血病(GVL)活性。从一项成人 allo-HCT 受者的观察性临床研究中,我们发现了一种不在起始移植物中存在的 CD4/CD8 双阳性 T 细胞(DPT)群体,其存在可预测≥2 级 GVHD。我们使用已建立的异种移植模型揭示,DPT 群体由抗原刺激的 CD8 T 细胞发展而来,这些细胞在转录、代谢和表型上与单阳性 CD4 和 CD8 T 细胞明显不同。当重新移植到幼稚小鼠中时,分离的 DPT 足以介导异种 GVHD 病理学,但当小鼠受到人 B-ALL 细胞系的挑战时,并没有提供生存获益。总的来说,这项研究揭示了人类 DPT 作为一种直接参与 GVHD 病理学的 T 细胞群体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8c5/10038349/e87a33607cc7/sciadv.adf0567-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8c5/10038349/1a8b79a91ef2/keyimage.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8c5/10038349/515c6759a88c/sciadv.adf0567-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8c5/10038349/5238e56b3f01/sciadv.adf0567-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8c5/10038349/de02754eba9f/sciadv.adf0567-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8c5/10038349/eea3143e973a/sciadv.adf0567-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8c5/10038349/f3daadfbc759/sciadv.adf0567-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8c5/10038349/43336dda042e/sciadv.adf0567-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8c5/10038349/544589838707/sciadv.adf0567-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8c5/10038349/e87a33607cc7/sciadv.adf0567-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8c5/10038349/1a8b79a91ef2/keyimage.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8c5/10038349/515c6759a88c/sciadv.adf0567-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8c5/10038349/5238e56b3f01/sciadv.adf0567-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8c5/10038349/de02754eba9f/sciadv.adf0567-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8c5/10038349/eea3143e973a/sciadv.adf0567-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8c5/10038349/f3daadfbc759/sciadv.adf0567-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8c5/10038349/43336dda042e/sciadv.adf0567-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8c5/10038349/544589838707/sciadv.adf0567-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8c5/10038349/e87a33607cc7/sciadv.adf0567-f8.jpg

相似文献

1
Inflammatory CD4/CD8 double-positive human T cells arise from reactive CD8 T cells and are sufficient to mediate GVHD pathology.炎性 CD4/CD8 双阳性人类 T 细胞源自反应性 CD8 T 细胞,足以介导移植物抗宿主病病理学。
Sci Adv. 2023 Mar 24;9(12):eadf0567. doi: 10.1126/sciadv.adf0567.
2
Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response.造血细胞移植后通过供体CD4+25 T细胞控制移植物抗宿主病以实现有效的移植物抗白血病反应。
Biol Blood Marrow Transplant. 2003 Apr;9(4):243-56. doi: 10.1053/bbmt.2003.50027.
3
CD8+ but not CD4+ T cells require cognate interactions with target tissues to mediate GVHD across only minor H antigens, whereas both CD4+ and CD8+ T cells require direct leukemic contact to mediate GVL.仅针对微小组织相容性抗原介导移植物抗宿主病(GVHD)时,CD8⁺而非CD4⁺T细胞需要与靶组织进行同源相互作用,而CD4⁺和CD8⁺T细胞介导移植物抗白血病效应(GVL)均需要与白血病细胞直接接触。
Blood. 2008 Apr 1;111(7):3884-92. doi: 10.1182/blood-2007-11-125294. Epub 2008 Jan 25.
4
Interleukin-12 preserves the graft-versus-leukemia effect of allogeneic CD8 T cells while inhibiting CD4-dependent graft-versus-host disease in mice.白细胞介素-12可保留同种异体CD8 T细胞的移植物抗白血病效应,同时抑制小鼠中CD4依赖的移植物抗宿主病。
Blood. 1997 Dec 1;90(11):4651-60.
5
A Novel Xenogeneic Graft-Versus-Host Disease Model for Investigating the Pathological Role of Human CD4 or CD8 T Cells Using Immunodeficient NOG Mice.一种新型异种移植物抗宿主病模型,用于利用免疫缺陷的NOG小鼠研究人CD4或CD8 T细胞的病理作用。
Am J Transplant. 2017 May;17(5):1216-1228. doi: 10.1111/ajt.14116. Epub 2016 Dec 21.
6
PD-1 and CTLA-4 up regulation on donor T cells is insufficient to prevent GvHD in allo-HSCT recipients.供体T细胞上PD-1和CTLA-4的上调不足以预防异基因造血干细胞移植受者的移植物抗宿主病。
PLoS One. 2017 Sep 27;12(9):e0184254. doi: 10.1371/journal.pone.0184254. eCollection 2017.
7
PD-L1 serves as a double agent in separating GVL from GVHD.程序性死亡受体配体1(PD-L1)在区分移植物抗白血病效应(GVL)和移植物抗宿主病(GVHD)方面起着双重作用。
J Clin Invest. 2017 May 1;127(5):1627-1630. doi: 10.1172/JCI94196. Epub 2017 Apr 17.
8
STING negatively regulates allogeneic T-cell responses by constraining antigen-presenting cell function.STING 通过限制抗原呈递细胞的功能来负调控同种异体 T 细胞反应。
Cell Mol Immunol. 2021 Mar;18(3):632-643. doi: 10.1038/s41423-020-00611-6. Epub 2021 Jan 26.
9
Daratumumab Prevents Experimental Xenogeneic Graft-Versus-Host Disease by Skewing Proportions of T Cell Functional Subsets and Inhibiting T Cell Activation and Migration.达雷妥尤单抗通过改变 T 细胞功能亚群的比例并抑制 T 细胞激活和迁移来预防实验性异种移植物抗宿主病。
Front Immunol. 2021 Dec 20;12:785774. doi: 10.3389/fimmu.2021.785774. eCollection 2021.
10
Mocravimod, a S1P receptor modulator, increases T cell counts in bone marrow biopsies from patients undergoing allogeneic hematopoietic stem cell transplantation.莫卡莫德,一种 S1P 受体调节剂,可增加接受异基因造血干细胞移植患者的骨髓活检中 T 细胞计数。
Cell Immunol. 2023 Jul;388-389:104719. doi: 10.1016/j.cellimm.2023.104719. Epub 2023 Apr 26.

引用本文的文献

1
CD4 skin resident memory T cells preferentially colocalize with dermal Folr2 macrophages in contact hypersensitivity.在接触性超敏反应中,CD4皮肤驻留记忆T细胞优先与真皮层Folr2巨噬细胞共定位。
Front Immunol. 2025 Jul 28;16:1590687. doi: 10.3389/fimmu.2025.1590687. eCollection 2025.
2
Intraepithelial lymphocytes in human oral diseases.人类口腔疾病中的上皮内淋巴细胞
Front Immunol. 2025 May 8;16:1597088. doi: 10.3389/fimmu.2025.1597088. eCollection 2025.
3
Rabies vaccination induces a CD4+ TEM and CD4+CD8+ TEMRA TH1 phenotype in dogs.

本文引用的文献

1
IL-33 acts as a costimulatory signal to generate alloreactive Th1 cells in graft-versus-host disease.IL-33 在移植物抗宿主病中作为共刺激信号产生同种反应性 Th1 细胞。
J Clin Invest. 2022 Jun 15;132(12). doi: 10.1172/JCI150927.
2
Single-cell immune profiling reveals a developmentally distinct CD4+ GM-CSF+ T-cell lineage that induces GI tract GVHD.单细胞免疫分析揭示了一种具有不同发育特征的 CD4+GM-CSF+T 细胞谱系,该谱系可诱导胃肠道移植物抗宿主病。
Blood Adv. 2022 May 10;6(9):2791-2804. doi: 10.1182/bloodadvances.2021006084.
3
HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamide.
狂犬病疫苗接种可在犬类中诱导出CD4+ 效应记忆T细胞(TEM)和CD4+CD8+ 终末分化记忆T细胞(TEMRA)TH1表型。
PLoS One. 2025 May 12;20(5):e0323823. doi: 10.1371/journal.pone.0323823. eCollection 2025.
4
Deep insight into cytokine storm: from pathogenesis to treatment.深入洞察细胞因子风暴:从发病机制到治疗。
Signal Transduct Target Ther. 2025 Apr 16;10(1):112. doi: 10.1038/s41392-025-02178-y.
5
Vitamin D exerts endogenous control over T2 cell fate and immune plasticity.维生素D对T2细胞命运和免疫可塑性发挥内源性控制作用。
iScience. 2025 Feb 26;28(4):112117. doi: 10.1016/j.isci.2025.112117. eCollection 2025 Apr 18.
6
Cell therapies for immune-mediated disorders.用于免疫介导性疾病的细胞疗法。
Front Med (Lausanne). 2025 Mar 26;12:1550527. doi: 10.3389/fmed.2025.1550527. eCollection 2025.
7
Hematopoietic stem cell microtransplantation: current situation and challenges.造血干细胞微移植:现状与挑战
Ther Adv Hematol. 2025 Jan 2;16:20406207241310332. doi: 10.1177/20406207241310332. eCollection 2025.
8
Pathophysiology and preclinical relevance of experimental graft-versus-host disease in humanized mice.人源化小鼠实验性移植物抗宿主病的病理生理学及临床前相关性
Biomark Res. 2024 Nov 14;12(1):139. doi: 10.1186/s40364-024-00684-9.
9
Epicardial transplantation of antioxidant polyurethane scaffold based human amniotic epithelial stem cell patch for myocardial infarction treatment.基于人羊膜上皮干细胞片的抗氧化聚氨酯支架的心脏外膜移植治疗心肌梗死。
Nat Commun. 2024 Oct 22;15(1):9105. doi: 10.1038/s41467-024-53531-8.
10
Immune reconstitution dynamics after unrelated allogeneic transplantation with post-transplant cyclophosphamide compared to classical immunosuppression with anti-thymocyte globulin: a prospective cohort study.与使用抗胸腺细胞球蛋白的经典免疫抑制相比,移植后使用环磷酰胺的非亲缘异基因移植后的免疫重建动力学:一项前瞻性队列研究。
Haematologica. 2025 Mar 1;110(3):640-650. doi: 10.3324/haematol.2024.285921.
HLA 可在接受移植后环磷酰胺治疗的单倍体造血干细胞移植后提供风险预测信息。
Blood. 2022 Mar 10;139(10):1452-1468. doi: 10.1182/blood.2021013443.
4
Antigen-specific T cell responses correlate with decreased occurrence of acute GVHD in a multicenter contemporary cohort.在一个多中心当代队列中,抗原特异性T细胞反应与急性移植物抗宿主病发生率降低相关。
Bone Marrow Transplant. 2022 Feb;57(2):279-281. doi: 10.1038/s41409-021-01456-x. Epub 2021 Oct 28.
5
Signatures of GVHD and relapse after posttransplant cyclophosphamide revealed by immune profiling and machine learning.免疫谱分析和机器学习揭示移植后环磷酰胺治疗后移植物抗宿主病和复发的特征。
Blood. 2022 Jan 27;139(4):608-623. doi: 10.1182/blood.2021013054.
6
Metabolomic identification of α-ketoglutaric acid elevation in pediatric chronic graft-versus-host disease.代谢组学鉴定儿童慢性移植物抗宿主病中 α-酮戊二酸升高。
Blood. 2022 Jan 13;139(2):287-299. doi: 10.1182/blood.2021013244.
7
The Pathophysiology and Treatment of Graft--Host Disease: Lessons Learnt From Animal Models.移植物抗宿主病的病理生理学与治疗:从动物模型中获得的经验教训
Front Immunol. 2021 Aug 19;12:715424. doi: 10.3389/fimmu.2021.715424. eCollection 2021.
8
Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host Disease.评估 Elafin 作为急性移植物抗宿主病的预后生物标志物。
Transplant Cell Ther. 2021 Dec;27(12):988.e1-988.e7. doi: 10.1016/j.jtct.2021.08.021. Epub 2021 Aug 30.
9
GVHD Pathogenesis, Prevention and Treatment: Lessons From Humanized Mouse Transplant Models.GVHD 的发病机制、预防和治疗:来自人源化小鼠移植模型的经验教训。
Front Immunol. 2021 Jul 29;12:723544. doi: 10.3389/fimmu.2021.723544. eCollection 2021.
10
HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis.HLA 单倍体相合与亲缘无关供者移植后应用环磷酰胺预防。
Blood. 2021 Jul 22;138(3):273-282. doi: 10.1182/blood.2021011281.